The company's fesoterodine fumarate extended-release tablets are available in 4 mg and 8 mg tablets, each in bottle count sizes of 30. These are the therapeutic generic equivalent of Toviaz, it added. Citing IQVIA data, Dr Reddy's said the Toviaz brand had US sales of approximately USD 211 million for the most recent 12 months ended May 2022.from Industry-Economic Times
Read The Rest:economictimes...
